Status:

COMPLETED

The PrEP (Pre-exposure Prophylaxis) SMART Study

Lead Sponsor:

University of Washington

Collaborating Sponsors:

Wits Reproductive Health and HIV Institute

National Institute of Mental Health (NIMH)

Conditions:

HIV/AIDS

Eligibility:

FEMALE

18-25 years

Phase:

NA

Brief Summary

The PrEP SMART study is testing a stepped model of scalable adherence support strategies in South African young women who initiate PrEP using a SMART (sequential multiple assignment randomized trial) ...

Detailed Description

Women enrolled in the study will be randomized to standard of care adherence support (brief counseling) and either WhatsApp groups or weekly two-way SMS messages. Two months after PrEP initiation, ten...

Eligibility Criteria

Inclusion

  • Female at birth
  • Age 18-25 years
  • Per participant report, sexually active, defined as having vaginal or anal intercourse at least once in the month prior to screening
  • Literate in one or more of the study languages
  • Willing and able to provide informed consent
  • Able and willing to provide adequate locator information
  • Regular access to a mobile phone with SMS and WhatsApp capacity
  • Agrees not to participate in other research studies involving drugs or medical devices for the duration of study participation

Exclusion

  • Planning to relocate in the next 12 months
  • Has a job or other obligations that would require long absences from the area (\> 4 weeks at a time) for 12 months
  • A reactive or positive HIV test at Enrollment
  • Any reported PrEP use within the last 6 months
  • Concomitant participation in a clinical trial using investigational agents, including placebo-controlled clinical trials using such agents
  • Prior participation in the active arm, or current participation in any arm, of an HIV vaccine trial
  • Positive pregnancy test

Key Trial Info

Start Date :

May 16 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 25 2022

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT04038060

Start Date

May 16 2019

End Date

January 25 2022

Last Update

September 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wits Reproductive Health and HIV Institute

Johannesburg, South Africa